NCT02686229 Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas
| NCT ID | NCT02686229 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ulm |
| Condition | Glioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2015-11-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2015-11-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.
Eligibility Criteria
Inclusion Criteria: * Patients with radiological suspected diagnosis of a low grade glioma * Age ≥ 18 years. There is no upper age limit. Exclusion Criteria: * Severe neurological or psychiatric disorder interfering with ability to give an informed consent * No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation * No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT02686229 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Glioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02686229 currently recruiting?
Yes, NCT02686229 is actively recruiting participants. Contact the research team at jan.coburger@uni-ulm.de for enrollment information.
Where is the NCT02686229 trial being conducted?
This trial is being conducted at Ulm, Germany.
Who is sponsoring the NCT02686229 clinical trial?
NCT02686229 is sponsored by University of Ulm. The trial plans to enroll 300 participants.